Ono’s Half-Year Operating Profit Up 25.1% on Double-Digit Drop in R&D, SGA Costs Amid COVID-19

Ono Pharmaceutical’s first-half group operating profit swelled 25.1% year on year to 52,401 million yen thanks to decreases in its R&D spending and SGA expenses, according to its earnings released on October 29. In April-September 2020, the company’s R&D spending...read more